Biomarkers for prostate cancer

The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investi...

Full description

Saved in:
Bibliographic Details
Main Authors Thaxton, Colby Shad, Smith, Norm D, Pazona, Joseph, Okotie, Onisuru T
Format Patent
LanguageEnglish
Published 05.10.2010
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy).